Treatment adherence among sputum smear-positive pulmonary tuberculosis patients in Xinjiang, China: a prospective study
- PMID: 35539878
- PMCID: PMC9078584
- DOI: 10.1039/c7ra11820a
Treatment adherence among sputum smear-positive pulmonary tuberculosis patients in Xinjiang, China: a prospective study
Abstract
Background: Despite great effort to control tuberculosis (TB), low treatment adherence threatens the success of drug therapy, increases the risk of TB transmission, and leads to the development of drug resistance. The present study assessed anti-TB treatment adherence in sputum smear-positive TB patients and examined the risk factors for poor patient adherence to identify targets for intervention.
Methods: We monitored and followed up TB patients who were diagnosed between July 2014 and June 2015 in Xinjiang, China. A total of 8289 sputum smear-positive TB patients were included in this study. All patients registered their information during the first hospital visit or with the Centers for Disease Control, had regular follow-up visits, and accepted the anti-TB treatment. Insufficient re-examination adherence was defined as undergoing fewer than the recommended three sputum smear examinations during the treatment course.
Results: Among 8289 patients, 3827 men (84.4% of male patients) and 3220 women (85.7% of female patients) had good adherence during treatment follow-up. 1242 patients (15.0%) did not complete regular follow-up. 332 (4.0%) patients lost contact. An adjusted logistic regression model showed that ethnicity, household address, treatment classification, patient source, and the actual management were significantly associated with non-adherence.
Conclusion: The Xinjiang TB epidemic situation remains grim. Smear-positive patients had a higher proportion of non-adherence, which increased treatment difficulties and the risk of death from TB. Relevant medical departments should strengthen their supervision and interventions during the TB treatment process to improve patient adherence to anti-TB treatment.
This journal is © The Royal Society of Chemistry.
Conflict of interest statement
All authors do not have a conflict of interest.
Similar articles
-
Treatment adherence among sputum smear-positive pulmonary tuberculosis patients in mountainous areas in China.BMC Health Serv Res. 2011 Dec 16;11:341. doi: 10.1186/1472-6963-11-341. BMC Health Serv Res. 2011. PMID: 22176718 Free PMC article.
-
API TB Consensus Guidelines 2006: Management of pulmonary tuberculosis, extra-pulmonary tuberculosis and tuberculosis in special situations.J Assoc Physicians India. 2006 Mar;54:219-34. J Assoc Physicians India. 2006. PMID: 16800350
-
Low sputum smear positive tuberculosis among pulmonary tuberculosis suspects in a tertiary hospital in Mwanza, Tanzania.Tanzan J Health Res. 2012 Apr;14(2):115-20. doi: 10.4314/thrb.v14i2.4. Tanzan J Health Res. 2012. PMID: 26591732
-
Adherence to tuberculosis treatment, sputum smear conversion and mortality: a retrospective cohort study in 48 Rwandan clinics.PLoS One. 2013 Sep 16;8(9):e73501. doi: 10.1371/journal.pone.0073501. eCollection 2013. PLoS One. 2013. PMID: 24066053 Free PMC article.
-
[Tuberculosis in Asia].Kekkaku. 2002 Oct;77(10):693-7. Kekkaku. 2002. PMID: 12440145 Japanese.
Cited by
-
Differences in CT imaging signs between patients with tuberculosis and those with tuberculosis and concurrent lung cancer.Am J Transl Res. 2022 Sep 15;14(9):6234-6242. eCollection 2022. Am J Transl Res. 2022. PMID: 36247264 Free PMC article.
-
Profile and risk factors of pre-XDR-TB and XDR-TB patients in a national reference hospital for Sumatra region of Indonesia.Narra J. 2023 Dec;3(3):e407. doi: 10.52225/narra.v3i3.407. Epub 2023 Nov 13. Narra J. 2023. PMID: 38455612 Free PMC article.
-
eDOTS: Improving the Treatment of Pulmonary Tuberculosis in Xinjiang, China.Infect Drug Resist. 2023 Dec 7;16:7497-7505. doi: 10.2147/IDR.S438962. eCollection 2023. Infect Drug Resist. 2023. PMID: 38089961 Free PMC article.
-
Integrating narrative and bibliometric approaches to examine factors and impacts of tuberculosis treatment non-compliance.Multidiscip Respir Med. 2025 Feb 28;20(1):1016. doi: 10.5826/mrm.2025.1016. Multidiscip Respir Med. 2025. PMID: 40017294 Free PMC article.
-
Prevalence and predictive factors of tuberculosis treatment interruption in the Asia region: a systematic review and meta-analysis.BMJ Glob Health. 2023 Jan;8(1):e010592. doi: 10.1136/bmjgh-2022-010592. BMJ Glob Health. 2023. PMID: 36650014 Free PMC article.
References
-
- World Health Organization, Global Tuberculosis Report, World Health Organization, Geneva, 2015
-
- Hassan A. Fattouh M. Atteya I. Mohammadeen H. Ahmed H. Validation of a rapid tuberculosis PCR assay for detection of MDR-TB patients in Sohag University Hospital. Stud. Conserv. 2014;56(4):281–297.
-
- Gurung G. N. Chhetri P. S. Jha N. Economic impact of pulmonary tuberculosis on patients and their families of Dharan municipality. Nepal Med. Coll. J. 2012;14:196–198. - PubMed
-
- Duanmu H. The prevalence of pulmonary tuberculosis in a national survey across China in 2010. Zhonghua Jiehe He Huxi Zazhi. 2012;35:665–668. - PubMed
LinkOut - more resources
Full Text Sources